bexarotene has been researched along with Multiple Sclerosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Brown, JWL; Chard, DT; Coles, AJ; Cunniffe, NG; Franklin, RJM; McMurran, CE; Michell, AW; Mukherjee, T | 1 |
Altmann, DR; Brown, JWL; Chandran, S; Chard, D; Coles, A; Connick, P; Cunniffe, NG; Daruwalla, C; Franklin, R; Georgieva, ZG; Jones, JL; Kanber, B; MacManus, D; Needham, EJ; Prados, F; Samson, R; Stutters, J; Wheeler-Kingshott, CG | 1 |
Bielekova, B; Crawford, AH; de la Fuente, AG; Fitzgerald, DC; Franklin, RJ; Johnson, KR; Linehan, E; Natrajan, MS; Nuñez, V; Ricote, M; Wu, T | 1 |
3 other study(ies) available for bexarotene and Multiple Sclerosis
Article | Year |
---|---|
Remyelination in humans due to a retinoid-X receptor agonist is age-dependent.
Topics: Age Factors; Aged; Animals; Bexarotene; Evoked Potentials, Visual; Humans; Multiple Sclerosis; Optic Nerve Diseases; Peripheral Nervous System Agents; Remyelination; Retinoid X Receptors; Retinoids | 2022 |
Remyelination varies between and within lesions in multiple sclerosis following bexarotene.
Topics: Bexarotene; Brain; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Remyelination | 2022 |
Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination.
Topics: Adult; Aging; Animals; Benzoates; Bexarotene; Biphenyl Compounds; Female; Humans; Macrophages; Male; Mice; Mice, Knockout; Middle Aged; Monocytes; Multiple Sclerosis; Myelin Sheath; Phagocytosis; Retinoid X Receptor alpha; Signal Transduction; Tetrahydronaphthalenes; Transcriptome; Young Adult | 2015 |